Glimestar-PM2 Tablet ER
Marketer
Mankind Pharma Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glimestar-PM2 Tablet ER
Diabetic patients with type 2 mellitus can benefit from Glimestar-PM2 ER tablets, a dual-action medication designed to regulate blood glucose. This medication complements diet and exercise, enhancing blood sugar management in adults. Its mechanism involves improved insulin utilization, resulting in reduced blood sugar. Always adhere to your physician's prescribed dosage and frequency for Glimestar-PM2 ER, taking it with food to prevent gastrointestinal discomfort. Missed doses should be taken promptly unless nearing the next scheduled dose; avoid doubling the dose. Excessive intake can trigger hypoglycemia (low blood sugar). Concurrent use with other antidiabetic medications, alcohol, or skipped meals may increase hypoglycemia risk; regular blood glucose monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals must consult their physician before use. Kidney function tests will be conducted before treatment begins. Limit alcohol consumption as it can heighten the risk of adverse effects.
Uses of Glimestar-PM2 Tablet ER
Managing type 2 diabetes
Major Benefits of Glimestar-PM2 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Glimestar-PM2 Tablet ER. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Consume with food.
Common Side effects of Glimestar-PM2 Tablet ER:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glimestar-PM2 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glimestar-PM2 Tablet ER whole; avoid chewing, crushing, or breaking it. Administer this medication with a meal.
How Glimestar-PM2 Tablet ER works:
Glimestar-PM2 Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their synergistic action improves blood glucose management when monotherapy or dual-drug regimens prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimestar-PM2 ER tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimestar-PM2 Extended-Release tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Glimestar-PM2 tablet is likely not safe for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Glimestar-PM2 Tablet ER; dosage modification may be necessary. Consult your physician for guidance. Glimestar-PM2 Tablet ER is contraindicated in patients with severe kidney disease. Routine monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with hepatic impairment should use Glimestar-PM2 Extended-Release tablets cautiously; dosage modification may be necessary. Physician consultation is advised. Glimestar-PM2 Extended-Release tablets are contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Glimestar-PM2 Tablet ER :
Should you forget a Glimestar-PM2 Extended-Release Tablet, take it immediately if remembered. However, near the time for your next dose, omit the missed one and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Glimestar-PM2 Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Treatment | Diabetes Management |






